BOSTONGENE
LIVE

Serial Number

90089889

Owner

BostonGene Corporation

Attorney

Christina M. Licursi

Filing Date

Aug 3, 2020

Add to watchlist:

No watchlists yet
View on USPTO

BOSTONGENE Trademark

Serial Number: 90089889 • Registration: 6457963

BOSTONGENE is a trademark filed by BostonGene Corporation on August 3, 2020. The trademark is classified under Class 42 (Computer & Scientific), Class 44 (Medical Services). The application is currently registered and active.

Owner Contact Info

BostonGene Corporation (7 trademarks)

Waltham, MA 02453

Entity Type: 03

Trademark Details

Filing Date

August 3, 2020

Registration Date

August 17, 2021

Goods & Services

Genetic testing for medical purposes, specifically, genomic, proteomic, transcriptomic, and molecular medical testing for cancer and other diagnostic or treatment purposes; Providing medical information, namely, providing collected and analyzed medical information in the field of genetic and treatment information for cancer and other diseases and disorders for diagnostic and treatment purposes; Providing medical information, specifically, providing collected and analyzed medical information in the field of genomics, proteomics, transcriptomics for diagnostic and treatment purposes; providing medical data and information to healthcare professionals; providing online computer databases of genomic sequences for medical scientific research, namely, for medical tracking, matching, searching, testing, aggregating, researching, and evaluating health status, for the purpose of diagnosing diseases and gene mutations; providing an online Internet website portal featuring medical information, namely, medical, genetic, genomic, proteomic, and transcriptomic information and data in the field of cancer for diagnostic and treatment purposes; providing an online Internet website portal featuring medical information, namely, medical, genetic, genomic, proteomic, and transcriptomic information and data for scientific, laboratory, and medical research and development purposes

Medical research services; biomedical research services; structural and functional analysis of genomes; scientific research in the field of genomics; medical laboratory services being medical research, in the fields of diagnostics and development of tests for clinical diagnosis and the detection of medical conditions and disorders; providing temporary use of online, non-downloadable software for genetic assessment and identification of cancer, diseases, health status and metrics, and gene mutations for scientific, medical, diagnostic, treatment, and research purposes; providing temporary use of online, non-downloadable software used for the sequencing and analyses of genomic, proteomic, and transcriptomic data; providing temporary use of online, non-downloadable software used to integrate and create data models; software as a service (SAAS) services featuring software for analyzing and visualizing genomic, proteomic, and transcriptomic data, and evaluating health status and diagnosing diseases, disorders, and syndromes; software as a service (SAAS) services featuring software for data management, for electronic storage of data in the field of clinical trials and electronic health records; software as a service (SAAS) services featuring software for patient treatment protocols and for recommending treatments to patients; providing online, non-downloadable computer software for collecting, analyzing, reporting, and tracking data and information in the fields of genetics, genomics, proteomics, transcriptomics, and biochemistry; providing online, non-downloadable software for use in clinical trial data management and for management of electronic health records

Filing History

REGISTERED-SUPPLEMENTAL REGISTER
Aug 17, 2021 R.SR
LAW OFFICE PUBLICATION REVIEW COMPLETED
Jul 13, 2021 PREV
ASSIGNED TO LIE
Jul 12, 2021 ALIE
APPROVED FOR REGISTRATION SUPPLEMENTAL REGISTER
Jul 9, 2021 CNTA
TEAS/EMAIL CORRESPONDENCE ENTERED
Jun 28, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Jun 28, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Jun 28, 2021 TROA
NOTICE OF ACCEPTANCE OF AMENDMENT TO ALLEGE USE E-MAILED
Jun 25, 2021 AAUA
USE AMENDMENT ACCEPTED
Jun 24, 2021 IUAA
AMENDMENT TO USE PROCESSING COMPLETE
Jun 9, 2021 AUPC
USE AMENDMENT FILED
Jun 9, 2021 IUAF
TEAS AMENDMENT OF USE RECEIVED
Jun 8, 2021 EAAU
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Mar 12, 2021 GNRN
NON-FINAL ACTION E-MAILED
Mar 12, 2021 GNRT
NON-FINAL ACTION WRITTEN
Mar 12, 2021 CNRT
TEAS/EMAIL CORRESPONDENCE ENTERED
Mar 10, 2021 TEME
CORRESPONDENCE RECEIVED IN LAW OFFICE
Mar 10, 2021 CRFA
TEAS RESPONSE TO OFFICE ACTION RECEIVED
Mar 10, 2021 TROA
NOTIFICATION OF NON-FINAL ACTION E-MAILED
Nov 23, 2020 GNRN
NON-FINAL ACTION E-MAILED
Nov 23, 2020 GNRT
NON-FINAL ACTION WRITTEN
Nov 23, 2020 CNRT
ASSIGNED TO EXAMINER
Nov 23, 2020 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Sep 1, 2020 NWOS